Get the Stockscreener App
287.61
2.42%
-7.12
After Hours:
289.77
2.16
+0.75%
Overview
News
Price History
Option Chain
Financials
Why CI Down?
Discussions
Forecast
Stock Split
Dividend History
Cigna Group stock is traded at $287.61, with a volume of 1.41M.
It is down -2.42% in the last 24 hours and up +4.20% over the past month.
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense (current contract through 2029), and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of December 2024.
See More
Previous Close:
$294.73
Open:
$294.73
24h Volume:
1.41M
Relative Volume:
0.79
Market Cap:
$75.77B
Revenue:
$216.66B
Net Income/Loss:
$6.25B
P/E Ratio:
12.96
EPS:
22.1869
Net Cash Flow:
$7.44B
1W Performance:
+1.08%
1M Performance:
+4.20%
6M Performance:
+2.55%
1Y Performance:
-1.74%
1-Day Range:
$286.50
$297.00
1-Week Range:
$283.19
$297.80
52-Week Range:
$239.51
$350.00
Cigna Group Stock (CI) Company Profile
Name
Cigna Group
Sector
Industry
Phone
(860) 226-6000
Address
900 COTTAGE GROVE ROAD, BLOOMFIELD, CT
Compare CI vs UNH, CVS, ELV, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CI
Cigna Group
|
287.61 | 77.65B | 216.66B | 6.25B | 7.44B | 22.19 |
|
UNH
Unitedhealth Group Inc
|
284.37 | 252.65B | 447.57B | 12.81B | 16.08B | 13.19 |
|
CVS
Cvs Health Corp
|
77.93 | 97.99B | 402.11B | 1.73B | 7.81B | 1.3835 |
|
ELV
Elevance Health Inc
|
336.04 | 72.89B | 199.13B | 5.66B | 3.17B | 25.11 |
|
HUM
Humana Inc
|
178.83 | 21.10B | 126.36B | 1.30B | 1.55B | 10.67 |
Cigna Group Stock (CI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-14-25 | Initiated | Goldman | Buy |
| Feb-06-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Jun-26-24 | Initiated | Piper Sandler | Overweight |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Mar-06-24 | Initiated | Barclays | Overweight |
| Feb-05-24 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Feb-05-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Feb-01-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-04-24 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Dec-11-23 | Upgrade | Jefferies | Hold → Buy |
| Aug-18-23 | Downgrade | Edward Jones | Buy → Hold |
| Jun-06-23 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Neutral |
| Apr-05-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jan-03-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Nov-23-22 | Resumed | Morgan Stanley | Overweight |
| Nov-21-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Jul-14-22 | Downgrade | Jefferies | Buy → Hold |
| Jun-22-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jun-17-22 | Initiated | Loop Capital | Hold |
| May-27-22 | Resumed | Bernstein | Mkt Perform |
| May-26-22 | Upgrade | BofA Securities | Underperform → Neutral |
| May-16-22 | Upgrade | JP Morgan | Neutral → Overweight |
| May-09-22 | Upgrade | Cowen | Market Perform → Outperform |
| Feb-07-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Feb-04-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-06-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-21-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-16-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-14-21 | Initiated | Goldman | Neutral |
| Nov-17-21 | Initiated | Seaport Research Partners | Buy |
| Sep-27-21 | Initiated | SVB Leerink | Mkt Perform |
| Sep-10-21 | Downgrade | BofA Securities | Buy → Underperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Aug-06-21 | Reiterated | BofA Securities | Buy |
| Aug-06-21 | Reiterated | Citigroup | Buy |
| Aug-06-21 | Reiterated | Deutsche Bank | Buy |
| Aug-06-21 | Reiterated | Jefferies | Buy |
| Aug-06-21 | Reiterated | Mizuho | Buy |
| Aug-06-21 | Reiterated | Oppenheimer | Outperform |
| Aug-06-21 | Reiterated | Truist | Buy |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Jul-01-20 | Initiated | SVB Leerink | Mkt Perform |
| May-04-20 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Mar-24-20 | Upgrade | Raymond James | Outperform → Strong Buy |
| Dec-11-19 | Downgrade | Wells Fargo | Market Perform → Underperform |
| Oct-18-19 | Initiated | Mizuho | Buy |
| Sep-30-19 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| Aug-06-19 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Apr-23-19 | Initiated | UBS | Buy |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Dec-24-18 | Initiated | Edward Jones | Buy |
| Mar-13-18 | Initiated | Bernstein | Mkt Perform |
| Mar-08-18 | Initiated | Barclays | Overweight |
| Jan-03-18 | Initiated | Goldman | Neutral |
| Nov-03-17 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-22-17 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-12-17 | Initiated | Credit Suisse | Outperform |
| Jun-07-17 | Initiated | Morgan Stanley | Overweight |
| May-08-17 | Reiterated | RBC Capital Mkts | Outperform |
| Apr-05-17 | Initiated | Deutsche Bank | Buy |
View All
Cigna Group Stock (CI) Latest News
LSV Asset Management Sells 13,080 Shares of Cigna Group $CI - MarketBeat
Rhumbline Advisers Decreases Position in Cigna Group $CI - MarketBeat
5 Revealing Analyst Questions From Cigna’s Q4 Earnings Call - The Globe and Mail
Caprock Group LLC Makes New $4.12 Million Investment in Cigna Group $CI - MarketBeat
5 Revealing Analyst Questions From Cigna's Q4 Earnings Call - Finviz
Cigna Downsizes Center City Office Footprint: The Philadelphia Deal Sheet (February 11, 2026) - Bisnow
Cigna Group (CI) Is Up 8.5% After Massive Buyback, Dividend Hike And Higher 2025 Earnings – Has The Bull Case Changed? - simplywall.st
Mark Cuban Urges Trump To 'Put His Weight Behind' Josh Hawley, Elizabeth Warren's 'Break Up Big Medicine Act' - Benzinga
This Week's Healthcare Earnings: Lilly, Cigna And More - Law360
How Investors Are Reacting To Cigna Group (CI) Earnings Beat, Massive Buybacks And Dividend Hike - Yahoo Finance
Cigna to lay off 2,000 workers worldwide - Healthcare Dive
Cigna to Remedy Years of Unfair Business Practices with Patients and Pharmacies - Drug Topics
Cigna to cut 2,000 jobs - Healthcare Finance News
Deutsche Bank Aktiengesellschaft Forecasts Strong Price Appreciation for Cigna Group (NYSE:CI) Stock - MarketBeat
Deutsche Bank Raises Price Target on Cigna Group to $304 From $301, Keeps Buy Rating - marketscreener.com
Cigna Group $CI Shares Acquired by Oppenheimer Asset Management Inc. - MarketBeat
Providence Capital Advisors LLC Acquires 7,748 Shares of Cigna Group $CI - MarketBeat
Cigna to cut 2,000 positions this month - Modern Healthcare News
Cigna Healthcare Returns as Title Sponsor of the Denver Colfax Marathon - Endurance Sportswire
UBS Maintains Cigna Group(CI.US) With Buy Rating, Cuts Target Price to $375 - 富途牛牛
The Cigna Group Named Top Dividend Stock With Insider Buying and 2.14% Yield (CI) - Nasdaq
CI: TD Cowen Raises Price Target for Cigna Group to $338 | CI St - GuruFocus
Landmark Settlement: The Cigna Group Resolves FTC Insulin Pricing Suit, Reshaping the PBM Landscape - FinancialContent
Cigna Group (NYSE:CI) Price Target Raised to $338.00 - MarketBeat
Cigna Group (NYSE:CI) Stock Price Expected to Rise, Jefferies Financial Group Analyst Says - MarketBeat
Cigna Stock: Is Wall Street Bullish or Bearish? - Barchart.com
Present Moments Recovery Now In-Network with Cigna & Evernorth Be - The National Law Review
TD Cowen Maintains Cigna Group(CI.US) With Buy Rating, Raises Target Price to $338 - 富途牛牛
Jefferies Adjusts Price Target on Cigna to $333 From $310, Maintains Buy Rating - marketscreener.com
TD Cowen Adjusts Price Target on Cigna to $338 From $333, Maintains Buy Rating - marketscreener.com
The Cigna Group Reports Strong Fourth Quarter and Full Year 2025 Results, Establishes 2026 Outlook and Increases Dividend - Eastern Progress
A Look At Cigna Group (CI) Valuation After Earnings Beat Dividend Hike And FTC Settlement - simplywall.st
There's Been No Shortage Of Growth Recently For Cigna Group's (NYSE:CI) Returns On Capital - Yahoo Finance
Cigna FTC Settlement Reshapes Express Scripts Model And Investor Outlook - Sahm
Bloomfield-based health-care giant Cigna Group and FTC settle insulin-price lawsuit - CT Insider
Savant Capital LLC Has $3.35 Million Position in Cigna Group $CI - MarketBeat
Cigna Group (NYSE:CI) Upgraded to Buy at Wall Street Zen - MarketBeat
Cigna Executives See Little ’26 Movement in Enrollment, Cost Ratio - HCI Innovation Group
FTC Deal Reshapes Cigna’s Express Scripts Margins And PBM Positioning - Sahm
Cigna Group (CI) Analyst Rating Update: RBC Capital Maintains wi - GuruFocus
News | Insurance giant Cigna sheds half of its downtown Philadelphia hub - CoStar
Is The Cigna Group Gaining or Losing Market Support? - Benzinga
Cigna Shows Greater Stability Amid Policy Uncertainty, RBC Says - marketscreener.com
Cigna Group (CI) Buy Rating Maintained by Guggenheim with Increa - GuruFocus
Cigna Group (CI) Analyst Rating: Barclays Lowers Price Target | - GuruFocus
Cigna Group (NYSE:CI) Announces Dividend Increase$1.56 Per Share - MarketBeat
Cigna Group (NYSE:CI) Given New $297.00 Price Target at Leerink Partners - MarketBeat
Royal Bank Of Canada Issues Pessimistic Forecast for Cigna Group (NYSE:CI) Stock Price - MarketBeat
BofA Securities Maintains Cigna Group(CI.US) With Buy Rating, Maintains Target Price $378 - 富途牛牛
RBC Trims Price Target on Cigna Group to $333 From $344, Keeps Outperform Rating - marketscreener.com
Cigna Corporation (NYSE:CI) Q4 2025 Earnings Call Transcript - Insider Monkey
Cigna Group Stock (CI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.75%
3.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):